期刊文献+

关注心肌淀粉样变的诊断线索 被引量:5

Focus on the diagnostic clues of cardiac amyloidoses
原文传递
导出
摘要 心肌淀粉样变是以心肌细胞间质前体蛋白沉积为特征的罕见疾病,表现为限制性心肌病,临床诊断困难。即使得到诊断,也往往忽视不同类型的心肌淀粉样变临床表现,且预后差异极大。本篇综述了AL型心肌淀粉样变的特点及临床表现,总结临床中易发现的线索,以提高该病的诊断率。 The cardiac amyloidose is an uncommon disease that characterized by the deposition of extracellular proteinaceous material known as amyloid.This rare disease,leading to an infiltrative/restrictive cardiomyopathy,is probably underdiagnosed.Even when a diagnosis of cardiac amyloidosis is made,the fact that there are several types of amyloid with unique features is often unrecognized.In this article we review the features of cardiac amyloidosis and its varied manifestations.The clues of clinical findings are helpful to improve the diagnosis of cardiac amyloidoses.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2014年第2期93-94,共2页 Journal of Clinical Cardiology
关键词 心肌淀粉样变 cardiac amyloidose
  • 相关文献

参考文献9

  • 1戴红芬,廖玉华,袁璟,付卿卿,曾淘,文建平.淀粉样变心肌病的诊断思路[J].临床心血管病杂志,2008,24(1):7-9. 被引量:5
  • 2FAI,K R H. I)iagnosis and management of the cardiac amyloidoses[J]. Circulation, 2005,112 : 2047 - 2060. 被引量:1
  • 3FALK R H. DUBREY S W. Amyloid heart disease [J] Prog (Tardiovasc Dis,2010.52:?;47-?,61. 被引量:1
  • 4WESTERMARK P. BENS()N M D, BUXBAUM J N, et al. A primer of amyloid nomenclature[J]. Am- yloid,2007,14 : 179- 183. 被引量:1
  • 5KW()NG R Y, FAI.K R H. Cardiovascular magnetic resonance in cardiac amyloidosis [J]. Circulation, 2005,111..122-12,t. 被引量:1
  • 6RUBERG F L, APPELBAUM E, DAVID()FF R, ct al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis[J]. Am J Cardiol, 2009,103 = 54,1 - 549. 被引量:1
  • 7MURTAGH B, HAMMILL S C, GERTZ M A, el al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement [-J~. AmJ Cardiol,2005.95:535-537. 被引量:1
  • 8MURTAGH B, HAMMII.I. S C, GERTZ M A. m al. Electrocardiographic finding,s .in primary systemic amyloidosis and Biopsy-proven c~rqlia<, involvement [J]. AmJ Cardiol,2005.95:535-537. 被引量:1
  • 9KATZMANN J A. ABRAHAM R S, DISPENZIERI A, et al. Diagnostic performance of quantitative kappa and lamhda free light chain assays in clinical practice[J]. ClinChem,2005,51:878-881. 被引量:1

二级参考文献12

  • 1廖玉华.从心肌病病因学研究走向临床诊断与治疗实践[J].中华心血管病杂志,2007,35(1):1-2. 被引量:26
  • 2MERLINI G, BELLOTTI V. Molecular mechanisms of amyloidosis[J]. N Engl J Med, 2003, 349:583-596. 被引量:1
  • 3WESTERMARK P, ARAKI S, BENSON M D, et al. Nomenclature of amyloid fibril proteins part l[J]. Amyloid, 1999,6: 63-66. 被引量:1
  • 4ROCKEN C, SHAKESPEARE A. Pathology, diagnosis and pathogenesis of AA amyloidosis[J]. Virchows Arch, 2002, 440:111-122. 被引量:1
  • 5HASSAN W, AL-SERGANI H, MOURAD W, et al. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management J]. Tex Heart Inst J, 2005, 32:178-184. 被引量:1
  • 6BRENNER D A, JAIN M, PIMENTEL D R, et al. Human amyloidogenic chains directly impair cardiomyocyte function through an increase in cellular oxidant stress[J]. Circ Res, 2004, 94: 1008-1010. 被引量:1
  • 7ANDERSSON K, OLOFSSON A, NIELSEN E H, et al. Only amyloidogenic intermediates of transthyretin induce apoptosis[J]. Biochem Biophys Res Commun, 2002, 294:309-314. 被引量:1
  • 8KINGMAN A, PEREIRA N L. Cardiac amyloidosis [J]. J Med Assoc, 2001, 97:201-206. 被引量:1
  • 9DISPENZIERI A, KYLE R A, GERTZ M A, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins[J]. Lancet, 2003, 361 : 1787-1789. 被引量:1
  • 10KOLSTOE S, WOOD S. Perspectives for drug intervention in amyloid diseases[J]. Curr Drug Targets, 2004, 5:151-158. 被引量:1

共引文献4

同被引文献30

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部